Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11237533 | 0.92 | TSHR (0.37) | TSHRTHRBFDPS | |
| SCHEMBL30094966 | 0.89 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL28899886 | 0.89 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL30620386 | 0.89 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL2430576 | 0.89 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL23579190 | 0.89 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL29160395 | 0.83 | — | — | |
| SCHEMBL28173577 | 0.81 | — | — | |
| SCHEMBL1691770 | 0.81 | — | — | |
| SCHEMBL20717686 | 0.81 | TSHR (0.44) | TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4065746-B1 | METHOD FOR DEPOSITING A FILM | VERSUM MAT US LLC (US) | 2024-09-04 | — | — | EP | claimed |
| CN-118434672-A | Method for removing water from bis (fluorosulfonyl) imide solution | 法国特种经营公司 | 2024-08-02 | — | — | CN | claimed |
| CN-116023425-B | Triamcinolone derivatives and medical application thereof | 南京师范大学 | 2023-06-20 | — | — | CN | claimed |
| CN-116023425-A | Triamcinolone derivatives and medical application thereof | 南京师范大学 | 2023-04-28 | — | — | CN | claimed |
| US-20230058258-A1 | METHOD FOR DEPOSITING A FILM | VERSUM MATERIALS US, LLC (US) | 2023-02-23 | — | — | US | claimed |
| EP-4065746-A1 | METHOD FOR DEPOSITING A FILM | Versum Materials US, LLC (US) | 2022-10-05 | — | — | EP | claimed |
| CN-115043895-A | PNU-159682 and preparation method of intermediate thereof | 戊言医药科技（上海）有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-110698527-B | Preparation method of high-purity hydrocortisone-17-valerate | 湖南新合新生物医药有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-114867888-A | Method for depositing a film | 弗萨姆材料美国有限责任公司 | 2022-08-05 | — | — | CN | claimed |
| WO-2021133774-A1 | METHOD FOR DEPOSITING A FILM | VERSUM MATERIALS US, LLC (US) | 2021-07-01 | — | — | WO | claimed |
| US-4252738-A | 1,2-Halohydrincarboxylic acid esters and a process for their preparation | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | claimed |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | AMBRX, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12485299-B2 | Antibody-immune agonist conjugate and applications thereof | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2025-12-02 | — | — | US | disclosed |
| CN-119455003-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119455004-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| US-4315032-A | ANTITHROMBOGENIC AGENTS, ANTIULCER AGENTS | TEITIN LIMITED (JP) | 1982-02-09 | — | — | US | disclosed |
| US-4252738-A | 1,2-Halohydrincarboxylic acid esters and a process for their preparation | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
| EP-0019475-A2 | Process for preparing adjacently disubstituted ketones, novel prostaglandins E1 and anti-thrombotic compositions containing them | TEIJIN LIMITED (JP) | 1980-11-26 | — | — | EP | disclosed |
| US-4113968-A | FROM A 1-HALO-3-ALKENE-2-OL | KURARAY CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-3975381-A | Process for preparing γ-lactone derivatives | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485299-B2 | Antibody-immune agonist conjugate and applications thereof | FCGR1A, FCGR2A, TLR3 | TSHR 501/4885LMNA 4493/4885THRB 1561/4885 |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | TLR3, TLR2, TLR1 | TSHR 821/4885LMNA 3756/4885THRB 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.